CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Exercise or conversion President, MWH acquired 1,307 shares (option exercise)
- 4 Open-market buy Director bought 5,860 shares at $25.60 ($149,998)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Grant or award Director acquired 11,687 shares (grant or award)
- 4 Open-market buy Director bought 7,000 shares at $23.46 ($164,223)
- 4 Returned to the company Exec. VP International Ops returned 7,153 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 11,942 shares (to the company)
- 4 Returned to the company President Crescendo BioScience returned 11,107 shares (to the company)
- 4 Returned to the company E.V.P., General Counsel returned 833 shares (to the company)
- 4 Returned to the company President Myriad RBM, Inc. returned 5,313 shares (to the company)
- 4 Returned to the company President Assurex Health Inc. returned 725 shares (to the company)
- 4 Returned to the company President, MWH returned 8,483 shares (to the company)
- 4 Returned to the company Chief Scientific Officer returned 10,701 shares (to the company)
- 4 Returned to the company President, MGL returned 1,182 shares (to the company)
Page 23 of 65 · 1,294 filings